Ligand validation:3T1D

DBS: 2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID

DBS is a Ligand Of Interest in 3T1D designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3T1D_DBS_B_181	33%	17%	0.195	0.875	2.27	1.34	3	4	1	0	100%	1
3T1D_DBS_C_179	14%	15%	0.222	0.776	0.82	2.86	-	7	2	0	100%	1
3BY0_DBS_A_191	48%	61%	0.193	0.935	0.63	0.84	-	1	0	0	100%	1
3CBC_DBS_A_301	19%	26%	0.202	0.795	1.96	1.06	1	2	0	0	100%	1
7SF6_DBS_A_402	90%	36%	0.083	0.965	0.97	1.52	-	2	0	0	100%	1
5ADV_DBS_A_1312	52%	30%	0.157	0.913	1.02	1.74	1	4	0	0	100%	1
6GI1_DBS_A_302	25%	13%	0.139	0.77	2.19	1.78	2	7	0	0	100%	0.8

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.